ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MBOT vs SKIN // RETURN ON INVESTED CAPITAL (ROIC)

Microbot Medical Inc. (NASDAQ) VS. SkinHealth Systems Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: MBOT 3 — SKIN 1
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: MBOT
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MBOT VS. SKIN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MBOT SKIN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 65.30% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -15.80% -26.90% +11.10 MBOT /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -17.42% — — TIE /fcf-yield <GO>
Operating Margin — -6.90% — TIE /operating-margins <GO>
Net Profit Margin — -3.20% — TIE /net-margins <GO>
Revenue Growth (YoY) — -10.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 6/9 -4.00 SKIN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 48.5 35.8 +12.70 MBOT /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $75.2M $66.0M $9.2M MBOT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MBOT REV SKIN REV MBOT GROSS % SKIN GROSS % MBOT FCF SKIN FCF
FY 2025 $0 $300.8M — 65.3% -$13.1M $37.2M
FY 2024 $0 $334.3M — 54.5% -$8.9M $15.4M
FY 2023 $0 $398.0M — — -$8.5M $21.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MBOT // BETA —
SKIN // BETA —